Home LiteratureArticle Details
PMID: 11890882 Published · ppublish English Journal Article Review

Reflex sympathetic dystrophy.

Current rheumatology reports ·Vol. 4 ·No. 2 ·2002-04-00 ·Pages 165-9

Schwartzman RJ, Popescu A

Abstract

Reflex sympathetic dystrophy (RSD) is composed of five major features: pain, swelling, autonomic dysregulation, movement disorders, and atrophy and dystrophy. RSD is caused by an injury to a specific nerve or the C- and A-delta fibers that innervate the involved tissue. It is a progressive illness that spreads with time and may encompass the entire body. There is no psychological disposition to the problem, but all patients are severely depressed because of the constant pain, lack of sleep, and complete disruption of their lifestyle. The continuing pain is usually secondary to the process of central sensitization. The autonomic dysregulation has a major central nervous system component. Atrophy and dystrophy are partly due to loss of nutritive blood supply to the affected tissues. The movement disorder is partly due to deficiency of GABAergic mechanisms; the tremor is an exaggeration of the normal physiologic tremor. Treatment consists of decreasing the afferent pain, maintaining barrage from the underlying defect, and blocking the sympathetic component of the process. New developments include the use of neurotrophic factors to reverse the phenotypic changes that occur in the dorsal horn and the use of pharmacologic agents to block the activity-dependent NMDA channels that appear to be instrumental in maintaining central sensitization.

MeSH Terms
Humans Reflex Sympathetic Dystrophy/diagnosis,therapy
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Schwartzman Robert J
Department of Neurology, MCP Hahnemann University School of Medicine, Broad and Vine Streets, MS 423, Philadelphia, PA 19102-1192, USA. [email protected]
Popescu Anca
References (22)
22 references, click to expand
  1. The molecular dynamics of pain control.
    Nat Rev Neurosci. 2001 Feb;2(2):83-91 PMID: 11252998
  2. Metabolic changes in reflex sympathetic dystrophy: a 31P NMR spectroscopy study.
    Muscle Nerve. 1993 Apr;16(4):367-73 PMID: 8455649
  3. Neuroimmune alterations in the complex regional pain syndrome.
    Eur J Pharmacol. 2001 Oct 19;429(1-3):101-13 PMID: 11698031
  4. Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1.
    Exp Neurol. 1998 May;151(1):138-42 PMID: 9582261
  5. The spinal component to skin blood flow abnormalities in reflex sympathetic dystrophy.
    Arch Neurol. 1996 Jan;53(1):58-65 PMID: 8599560
  6. Acute effects of substance P and calcitonin gene-related peptide in human skin--a microdialysis study.
    J Invest Dermatol. 2000 Dec;115(6):1015-20 PMID: 11121135
  7. Postinjury neuropathic pain syndromes.
    Med Clin North Am. 1999 May;83(3):597-626 PMID: 10386117
  8. Explaining reflex sympathetic dystrophy.
    Arch Neurol. 1999 May;56(5):521-2 PMID: 10328244
  9. An unusual case of chronic neuropathic pain responds to an optimum frequency of intravenous ketamine infusions.
    J Pain Symptom Manage. 2001 May;21(5):443-6 PMID: 11369165
  10. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain.
    Neurobiol Dis. 2001 Feb;8(1):1-10 PMID: 11162235
  11. The effects of the clinically tested NMDA receptor antagonist memantine on carrageenan-induced thermal hyperalgesia in rats.
    Eur J Pharmacol. 1994 Apr 1;255(1-3):123-9 PMID: 8026538
  12. Patterns of spread in complex regional pain syndrome, type I (reflex sympathetic dystrophy).
    Pain. 2000 Dec 1;88(3):259-66 PMID: 11068113
  13. Psychological dysfunction in patients with reflex sympathetic dystrophy.
    Pain. 1997 Jul;71(3):323-33 PMID: 9231876
  14. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy.
    N Engl J Med. 2000 Aug 31;343(9):618-24 PMID: 10965008
  15. Systemic lidocaine for neuropathic pain relief.
    Pain. 2000 Jul;87(1):7-17 PMID: 10863041
  16. New treatments for reflex sympathetic dystrophy.
    N Engl J Med. 2000 Aug 31;343(9):654-6 PMID: 10979798
  17. Pathobiology of neuropathic pain.
    Eur J Pharmacol. 2001 Oct 19;429(1-3):23-37 PMID: 11698024
  18. Vascular abnormalities in acute reflex sympathetic dystrophy (CRPS I): complete inhibition of sympathetic nerve activity with recovery.
    Arch Neurol. 1999 May;56(5):613-20 PMID: 10328258
  19. Tremor in reflex sympathetic dystrophy.
    Arch Neurol. 1991 Dec;48(12):1247-52 PMID: 1845027
  20. The movement disorder of reflex sympathetic dystrophy.
    Neurology. 1990 Jan;40(1):57-61 PMID: 2296383
  21. Neuropathic central pain: epidemiology, etiology, and treatment options.
    Arch Neurol. 2001 Oct;58(10):1547-50 PMID: 11594911
  22. Intrathecal baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophy.
    N Engl J Med. 2000 Aug 31;343(9):625-30 PMID: 10965009
Article Info
Journal
Current rheumatology reports
Abbr.
Curr Rheumatol Rep
ISSN
1523-3774
Published
2002-04-00
Pages
165-9
Language
English
Region
United States
NLM ID
100888970
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]